Shares of Rentokil Initial plc (LON:RTO - Get Free Report) crossed above its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of GBX 357.60 ($4.83) and traded as high as GBX 367.70 ($4.97). Rentokil Initial shares last traded at GBX 360.97 ($4.88), with a volume of 2,862,484 shares trading hands.
Wall Street Analysts Forecast Growth
Several analysts recently commented on the stock. Royal Bank Of Canada reissued an "outperform" rating and set a GBX 440 ($5.94) target price on shares of Rentokil Initial in a research note on Friday, August 1st. Deutsche Bank Aktiengesellschaft increased their target price on shares of Rentokil Initial from GBX 425 ($5.74) to GBX 435 ($5.88) and gave the company a "buy" rating in a research note on Monday, July 21st. Finally, JPMorgan Chase & Co. reissued a "no recommendation" rating on shares of Rentokil Initial in a research note on Monday, August 11th.
View Our Latest Analysis on RTO
Rentokil Initial Price Performance
The stock's fifty day moving average price is GBX 356.21 and its 200-day moving average price is GBX 357.60. The company has a debt-to-equity ratio of 113.35, a current ratio of 1.04 and a quick ratio of 1.76. The firm has a market cap of £9.04 billion, a price-to-earnings ratio of 23.15, a price-to-earnings-growth ratio of 0.56 and a beta of 0.55.
Insider Activity
In other news, insider Sally Johnson purchased 3,567 shares of the business's stock in a transaction dated Monday, June 2nd. The shares were acquired at an average price of GBX 351 ($4.74) per share, for a total transaction of £12,520.17 ($16,912.29). 0.32% of the stock is owned by corporate insiders.
About Rentokil Initial
(
Get Free Report)
Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom, rest of Europe, Asia, the Pacific, and internationally. It offers a range of pest control services for rodents, and flying and crawling insects, as well as other forms of wildlife management for commercial customers.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Rentokil Initial, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rentokil Initial wasn't on the list.
While Rentokil Initial currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.